chloride channels; cell volume; protein kinase C VOLUME-SENSITIVE ORGANIC OSMOLYTE and anion channels (VSOACs) are ubiquitously expressed in mammalian cells and play an important physiological role in a variety of diverse cellular functions, including the regulation of electrical activity, cell volume homeostasis, intracellular pH, immunological responses, cell proliferation, and differentiation (24, 27, 34) . The cellular and molecular mechanisms that link changes in cell volume to the activation of volume-sensitive Cl Ϫ currents (I Cl.vol ) are not well understood. Although changes in intracellular ionic strength have been proposed as the initial trigger for activation of I Cl.vol in some cell types (11, 37) , reorganization of the F-actin cytoskeleton during cell volume changes may result in changes in membrane physical properties or alterations of the properties or distribution of many proteins normally associated with the cell membrane. It has been suggested that membrane unfolding may be the stimulus for activation of I Cl.vol and that the F-actin cytoskeleton may modulate volume sensitivity of the channel by conferring resistance to this process (27) . It has recently been shown that caveolins, the principal protein of membrane caveolae, modulate the properties of I Cl.vol (36) . A number of protein kinases, which have been shown to play a role in cell volume regulation, including tyrosine kinase (35, 38) , Rho-associated kinase (25) , phosphatidylinositol (PI) 3-kinase (12) , and protein kinase C (PKC) (2, 6) , have all been shown to directly modulate the activity of I Cl.vol in a variety of different native cell types. However, a clear picture of the actual cascade of intracellular events linking cell volume changes to the regulation of I Cl.vol has yet to emerge. It is not even clear whether or not a single unifying mechanism for activation of I Cl.vol necessarily applies to all cells studied or whether different protein entities may be responsible for I Cl.vol in different cell types (7, 34) . We previously tested the hypothesis that PKC-catalysed phosphorylation and dephosphorylation by protein phosphatases may represent an important molecular link between changes in cell volume and I Cl.vol regulation in native cardiac myocytes, Xenopus oocytes, and the recent molecular candidate for VSOAC, guinea pig ClC-3 (gpClC-3) expressed in NIH/3T3 cells (5, 8, 32) . Hypotonic cell swelling was shown to activate, whereas hypertonic cell shrinkage was shown to deactivate, gpClC-3 currents (I gpClC-3 ) expressed in NIH/3T3 cells and I Cl.vol in native cardiac myocytes and Xenopus oocytes, effects that could be mimicked under isotonic conditions by inhibition (bisindolylma-leimide; BIM) and stimulation (phorbol esters), respectively, of endogenous PKC. Moreover, phosphatase inhibitors such as okadaic acid and calyculin A also inhibited I gp-ClC-3 , and mutation of an amino terminal PKC phosphorylation site (S51A) completely eliminated the response of expressed I gpClC-3 to cell swelling, resulting in a constitutively active channel under isotonic conditions which was insensitive to PKC activation and phosphatase inhibition. These results indicated that an important mechanism linking cell swelling to activation of I Cl.vol in native cardiac myocytes, Xenopus oocytes, and recombinant I gpClC-3 involves dephosphorylation of PKC-phosphorylated sites.
The properties of I Cl.vol have recently been studied in vascular smooth muscle cells of canine pulmonary artery, a cell type known to express endogenous ClC-3 (39), as well as rabbit portal vein (15) . The purpose of the present study was to 1) determine whether or not native I Cl.vol in pulmonary artery smooth muscle cells (PASMC) is regulated by PKC in a manner consistent with regulation of recombinant I gpClC-3, 2) determine which PKC isozymes are involved in the regulation of native I Cl.vol by changes in cell volume in PASMC, and 3) determine whether or not the cellular distribution of PKC isozymes in PASMC is altered by changes in cell volume. A preliminary report describing these results has been published (41) .
METHODS
Cell preparation. Mongrel dogs were anesthetized with pentobarbital sodium (45-50 mg kg Ϫ1 , iv). Segments of pulmonary artery were removed, and vascular smooth muscle cells were enzymatically dispersed as previously described (9, 39) . Freshly dispersed cells were kept in the refrigerator and used within 10 h. The animal use protocol was reviewed and approved by the Animal Care and Use Committee of the University of Nevada.
Electrophysiological recordings. Membrane currents were measured from canine PASMC at room temperature (22-24°C) by the tight-seal, whole cell, voltage-clamp technique (16) . Patch pipettes were made from borosilicate glass capillaries and had a tip resistance of 2-5 M⍀. Ag-AgCl wires were immersed in the bath and pipette solutions and connected to a patch-clamp amplifier (Axopatch-200A, Axon Instruments, Foster City, CA). A 3 M KCl-agar salt bridge between the bath and Ag-AgCl reference electrode was used to minimize changes in liquid junctional potential. To obtain Cl Ϫ current-voltage relations, whole cell currents were recorded during voltage pulses (150 ms) applied from the holding potential (Ϫ10 mV). The time courses of changes in membrane currents were monitored by the application of repetitive voltage-clamp steps to Ϯ80 mV applied every 30 s. Membrane currents were filtered at a frequency of 1 kHz and digitized online at 5 kHz using a Pentium III processor and pCLAMP 8 software (Axon Instruments).
Solutions and reagents. All bath and pipette solutions were chosen to facilitate Cl The PKC translocation inhibitory peptides ␤C2-2 (MD-PNGLSDPYVKL, corresponding to residues 186-198 of ␤PKC), ⑀V1-2 (EAVSLKPT, corresponding to residues 14-21 of ⑀PKC), and scrambled ⑀V1-2 (LSETKPAV) were synthesized in the University of Calgary Peptide Synthesis Core Facility using a Beckman model 990B automated peptide synthesizer and purified by preparative reverse-phase HPLC. Phorbol 12,13-dibutyrate (PDBu), calphostin C, Ro-31 8425, and BIM were purchased from Calbiochem (La Jolla, CA). These drugs were first dissolved in dimethylsulfoxide (DMSO) and then further diluted in the solution to a final concentration of DMSO of Ͻ0.2%. DMSO alone at 0.2% had no effect on Cl Ϫ currents. In Figs. 5-7, the onset of membrane rupture and intracellular dialysis is indicated at time 0.
Immunohistochemistry. PASMC were dispersed and cultured as previously described (40) . Special culture dishes were incorporated to aid with imaging. Holes were cut (23 mm) in the base of 35-mm culture dishes, and 25-mm glass coverslips were then bonded to the base of the dish. Cultured PASMC (48 h) were then exposed to isotonic (300 mosmol/ kgH 2O) and hypotonic (230 mosmol/kgH2O) solutions for 5, 10, and 20 min. After treatment, cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS, pH 7.4) for 10 min at 4°C. After fixation, cells were washed in PBS (4 ϫ 30 min), and nonspecific antibody binding was reduced by blocking with 10% bovine serum albumin in PBS containing 0.03% Triton X-100 for 1 h and then incubated with a polyclonal anti-PKC⑀ antibody raised in rabbit (Upstate Biotechnology, Lake Placid, NY) at a dilution of 1:200 for 24 h at 4°C. Cells were then washed with PBS (2 ϫ 10 min) and incubated in Alexa 488 (green fluorescence) conjugated goat anti-rabbit IgG secondary antibody (Molecular Probes) at 5 g/ml. Secondary incubations were performed for 1 h at room temperature. After secondary incubation, cells were washed in PBS (3 ϫ 15 min). For negative control cells, the primary antibody was omitted and substituted with PBS. Cells were examined using a Nikon Eclipse TE 300 inverted fluorescent microscope with excitation wavelength appropriate for Alexa 488 (488 nm). Digital micrographs were acquired using a Spot RT digital camera, and final images were prepared using Adobe Photoshop software.
For immunofluorescence quantitation, images were acquired of cultured PASMCs subjected to isotonic (n ϭ 11) or hypotonic (n ϭ 10) bath solutions for 20 min, keeping image acquisition parameters constant. Simple PCI software (Compix, Cranberry Township, PA) was used to select regions of interest (ROIs) and calculate pixel intensities. The initial ROIs chosen spanned the entire cell diameter for each image (see Fig. 8, A and C) . The pixel intensity across the ROI was then computed, and data were plotted graphically (see Fig. 8, B and D) . The ROI was a standard width, with length standardized to account for differences in cell size by having the ROI "overshoot" the membrane on either side of the cell by a fixed amount (2.5 m). Additional, multiple, smaller ROIs in each cell were sampled in 2 ϫ 4-m areas juxtaposed either close to the sarcolemmal membrane or close to the nuclear membrane, and mean pixel intensities in these areas were computed to compare differences between these regions in cells exposed to isotonic or hypotonic bath solutions.
Data were expressed as means Ϯ SE (n, no. of cells). Statistical analysis was made by paired t-tests and analysis of variance where appropriate. A value of P Ͻ 0.05 was considered to be statistically significant. Cl.vol Fig. 1A ). Cell swelling-induced increases in I Cl.vol were completely reversed by perfusion of cells with a hypertonic (370 mosmol/kgH 2 O) solution. Figure 1B illustrates that, in a group of cells, current densities measured at Ϯ80 mV were more than doubled after hypotonic challenge and returned to the basal level in response to exposure to hypertonic bath solutions. In another group of cells, when the activation of I Cl.vol in hypotonic solutions reached a steady state, 100 nM PDBu was applied to the hypotonic bath solution. As Fig. 2 . Lack of effect of bisindolylmaleimide (BIM) on ICl.vol in acutely dispersed canine PASMC. A: time course of currents recorded at Ϫ80 mV (F) followed by ϩ80 mV (E) from a cell that was superfused with isotonic, hypotonic, and hypertonic solutions at times indicated by horizontal bars. BIM was added to the isotonic solution and was removed when the superfusion was switched to a hypotonic solution. B: average current density under different experimental conditions. Values represent means Ϯ SE (n ϭ 7). * Significantly different from the values under isotonic conditions (P Ͻ 0.05).
RESULTS

Effect of PDBu on native I
shown in Fig. 1, C and D (5, 32) . Figure 2 shows the effect of the PKC inhibitor, BIM at 100 nM, on I Cl.vol . BIM at this concentration is a more potent inhibitor of conventional (c)PKCs than novel (n)PKCs (20) . Unlike native I Cl.vol in cardiac myocytes and expressed ClC-3 channels in NIH 3T3 cells (5), exposure to 100 nM BIM failed to activate I Cl.vol under isotonic conditions in PASMC. Current amplitudes after BIM exposure were not significantly different from the values without BIM (Fig. 2B) . I Cl.vol in cells treated with BIM were similar to those in control cells, being significantly increased under hypotonic conditions and reversed by exposure to hypertonic solutions. On the other hand, exposure of PASMC to another PKC inhibitor, calphostin C, which at 100 nM is reported to be an equally potent inhibitor of cPKCs and nPKCs (14) , increased I Cl.vol under isotonic conditions (Fig. 3) . Mean current densities in a group of cells was more than doubled by addition of calphostin C to the isotonic bath solution, whereas the current-voltage relationship of the calphostin C-induced current was unchanged by switching to hypotonic solutions (Fig. 3B) . Superfusion of cells with hypotonic solutions after treatment with calphostin C failed to further increase the current densities. Similarly, another equally potent inhibitor of cPKCs and nPKCs, Ro-31 8425 (14), also increased I Cl.vol densities under isotonic conditions and prevented further activation of the channels by subsequent hypotonic cell swelling (Fig. 4) .
These results strongly suggest that, similar to several other cell types, PKC-catalysed phosphorylation and dephosphorylation of PKC-phosphorylated sites play a crucial role in VSOAC regulation by changes in cell volume in canine PASMC. These results also suggest that the isoform of PKC involved in the volume regulation of these channels in PASMC may differ from other cell types. For instance, for native I Cl.vol in guinea pig cardiac myocytes, Xenopus oocytes, and recombinant ClC-3 Cl Ϫ channels expressed in NIH 3T3 cells, regulation by changes in cell volume may involve cPKCs, because currents were activated under isotonic conditions by exposure to BIM (5, 32), whereas in PASMC regulation of native I Cl.vol appears to involve nPKCs.
Effects of isozyme-specific PKC translocation inhibitory peptides on native I Cl.vol in canine PASMC.
To further test the hypothesis that nPKCs are responsible for the cell volume sensitivity of native I Cl.vol in PASMC, we examined the effects of different isozymespecific PKC translocation inhibitory peptides on these channels. ⑀V1-2 is a short peptide derived from the V1 region of ⑀PKC, which inhibits translocation of ⑀PKC Fig. 3 . Calphostin C activates ICl.vol in isotonic solutions in acutely dispersed PASMC and prevents further volume regulation of the current. A: representative current recordings when the cell membrane potential was stepped to potentials ranging from Ϫ100 to ϩ100 mV in 20-mV increments from a holding potential of Ϫ20 mV. a, b, and c show representative current recordings when the cell was superfused with isotonic, isotonic plus calphostin C, and hypotonic solutions, respectively. B: current-voltage relations measured from the same cell under different experimental conditions. C: time course of currents measured at Ϫ80 mV (F) followed by ϩ80 mV (E) from a cell under the same experimental conditions as marked. D: average current density from a group of cells tested under the different experimental conditions. Values represent means Ϯ SE (n ϭ 5). * Significantly different from the values under isotonic conditions (P Ͻ 0.05). (19, 21) . Figure 5 shows the effect of ⑀V1-2 on native I Cl.vol in PASMC. Cells were dialyzed with ⑀V1-2 (10 M) under isotonic conditions and subsequently exposed to hypotonic and then hypertonic solutions. Dialyzing the cells with ⑀V1-2 significantly increased I Cl.vol under isotonic conditions and abolished further regulation by either hypotonic cell swelling or hypertonic cell shrinkage (Fig. 5, A and B) . The mean current densities in cells dialyzed with ⑀V1-2 were increased 239 Ϯ 16% at ϩ80 mV and 100 Ϯ 8% at Ϫ80 mV under isotonic conditions, and the current densities measured at 10 min of intracellular dialysis in isotonic solutions were not significantly different from the values after superfusion with hypotonic or hypertonic solution. On the other hand, in cells dialyzed with the scrambled ⑀V1-2 peptide (10 M), current amplitudes were unchanged under isotonic conditions. In addition, cells dialyzed with scrambled ⑀V1-2 peptide responded in the usual manner to hypotonic and hypertonic solutions (Fig. 5, C and D) .
In another test, we examined the effects on I Cl.vol in PASMC of ␤C2-2, a synthetic peptide derived from the C2 region of ␤PKC, which inhibits translocation of conventional (Ca 2ϩ -dependent) PKC isozymes (cPKCs) (22) . As shown in Fig. 6 , intracellular dialysis with ␤C2-2 peptide (10 M) did not evoke any significant change in I Cl.vol under basal isotonic conditions, nor did it prevent I Cl.vol regulation by cell volume changes. Current densities measured at 1 and 10 min of isotonic superfusion were not different in cells dialyzed with ␤C2-2. Subsequent exposure of these cells to hypotonic solutions significantly increased current density, an effect which was reversed by hypertonic superfusion. Taken together, results with PKC translocation inhibitory peptides are consistent with those with different PKC inhibitors and further confirmed that ⑀PKC, a member of the nPKC family, plays a crucial role in cell volume regulation of native I Cl.vol in PASMC.
Alterations in cellular distribution of ⑀PKC in response to cell swelling. Although several different PKC isoforms have been shown to translocate in response to agonist stimulation in canine PASMC (4), the effects of changes in cell volume on PKC isoform cellular distribution have not been previously tested. We performed immunohistochemistry on cultured canine PASMC to examine ⑀PKC-like immunoreactivity in cells exposed to isotonic extracellular solutions and after hypotonic cell swelling. Before performing these experiments, we first confirmed that dialyzing cultured PASMC with the ⑀V1-2 peptide produced similar effects on I Cl.vol as previously observed in acutely dispersed PASMC (Fig. 7) . Figure 8A illustrates the typical pattern of immunoreactivity of a canine PASMC under isotonic conditions. ⑀PKC-like immunoreactivity showed a diffuse, uniform cytosolic and membrane disposition. This is illustrated in Fig. 8B in the plot of pixel intensity over the region of interest illustrated (rectangular box) in Fig. 8A . In contrast, there appeared to be a consistent decrease in near-membrane immunoreactivity (horizontal dashed lines) and a marked increase in cytoplasmic and perinuclear ⑀PKC-like immunoreactivity in cells exposed to hypotonic solutions for 20 min (Fig. 8, C and D) . These differences were quantitated by measuring mean pixel intensity in areas juxtaposed near the sarcolemmal membrane or near the nuclear membrane and compared in cells exposed to either isotonic or hyotonic bath solutions (Fig. 8D) . ⑀PKC-like immunoreactivity in regions near the sarcolemmal membrane were significantly lower in cells exposed to hypotonic solutions compared with similar regions in cells exposed to isotonic solutions. There also was a significant increase in ⑀PKC-like immunoreactivity in perinuclear regions in cells exposed to hypotonic solutions compared with similar regions in cells exposed to isotonic solutions. These data suggest that hypotonic cell swelling is associated with a translocation of ⑀PKC from the vicinity of the sarcolemmal membrane to the cytoplasm and perinuclear regions. 
DISCUSSION
For I Cl.vol in native cardiac myocytes, Xenopus oocytes, and recombinant ClC-3 Cl Ϫ channels expressed in NIH 3T3 cells, channels can be activated under isotonic conditions by exposure of cells to 100 nM BIM, a highly selective inhibitor of cPKCs (20) , whereas stimulation of endogenous PKC activity by phorbol esters strongly inhibits channel activity (5, 32) . These data suggest that I Cl.vol in native cardiac myocytes, Xenopus oocytes, and recombinant ClC-3 Cl Ϫ channels expressed in NIH 3T3 cells are regulated primarily by cPKCs, in a manner consistent with a model recently proposed which links changes in cell volume to changes in protein kinase-dependent phosphorylation of the channel (18) . Translocation of cPKC away from the channel during cell swelling would allow the phosphorylation/dephosphorylation equilibrium of the channel to favor dephosphorylation and channel opening, whereas translocation of cPKC toward the vicinity of the channel during cell shrinkage would allow the phosphorylation/dephosphorylation equilibrium of the channel to favor phosphorylation and channel closure. This equilibrium would also be expected to be strongly influenced by the activity of protein phosphatases, but the possible influence of cell volume changes on phosphatase activity or distribution remains to be determined. Because I Cl.vol in canine PASMC is also strongly inhibited by phorbol esters (Fig. 1 ), it appears that the same general model might account for cell volumeinduced changes in native I Cl.vol in PASMC as well. However, the observed inability of BIM exposure to activate I Cl.vol under isotonic conditions in these cells suggests the possibility that different PKC isoforms may be responsible for regulation of I Cl.vol in PASMC.
The possible role of nPKCs in the regulation of I Cl.vol in PASMC was tested using two PKC-specific inhibitors, calphostin C and the compound Ro-318425, and two PKC isozyme-specific translocation inhibitory peptides, ⑀V1-2 and ␤C2-2. Inhibition of endogenous PKC activity by either calphostin C or Ro-318425 caused activation of native I Cl.vol in PASMC under isotonic conditions and prevented further modulation of I Cl.vol by anisotonic-induced changes in cell volume. A similar effect was observed after intracellular dialysis of the ⑀V1-2 peptide, but not with dialysis of the ␤C2-2 peptide. These results are consistent with involvement of nPKC (most likely ⑀PKC), not cPKC isozymes, in the regulation of I Cl.vol in canine PASMC. Thus dialysis with the inhibitory peptide ⑀V1-2 may displace endogenous PKC⑀ from its anchoring protein, thus promoting dephosphorylation and channel activation. Indeed, immunohistochemistry of the subcellular distribution of PKC isozymes in canine PASMC provided evidence that hypotonic cell swelling is accompanied by translocation of ⑀PKC away from the membrane to cytoplasmic and perinuclear locations.
Considering the role of protein phosphorylation/dephosphorylation in the regulation of both native I Cl.vol and recombinant ClC-3 Cl Ϫ channels proposed here, it is important to consider the known relationship of PKC to the cytoskeleton and caveolae, which may be significantly altered during cell volume changes. An isoformspecific interaction between PKC⑀ and F-actin has been demonstrated in intact nerve endings, suggesting that F-actin may be a principal anchoring protein for PKC⑀ (30) . An additional study verified this interaction between PKC⑀ and F-actin in NIH 3T3 cells and suggested that this protein-protein interaction is required to maintain PKC⑀ in a catalytically active conformation (29) . Other studies have documented interactions of other PKC isozymes (PKC␤II and PKC) with Factin (1, 13) . PKC isozyme-specific interactions with caveolin-1 and -2, scaffolding proteins that organize a variety of signaling complexes within the caveolae, have also been demonstrated (26, 31) . If F-actin or caveolin serve as essential anchoring proteins for PKC isoforms, then a possible mechanism for the activation of I Cl.vol during cell swelling might involve reorganization of F-actin or alteration or redistribution of caveolar microdomains during cell swelling (3, 17, 23, 28) , causing PKC translocation to be altered or causing PKC to assume a catalytically inactive conformation, thus favoring dephosphorylation and channel activation. Such interactions between PKC and F-actin or caveolin may also play a role in the ability of some cellular enzymes and second messengers, known to be altered during cell volume regulation, to effect changes in I Cl.vol , because PKC isoforms are believed to represent upstream effectors for several of these pathways as well.
Despite cell-specific differences in PKC isoform regulation of native I Cl.vol in canine PASMC compared with native I Cl.vol in cardiac cells and Xenopus oocytes, and recombinant ClC-3 channels expressed in NIH 3T3 cells (5) , these currents all exhibit a similar general sensitivity to regulation by PKC activation and inhibition. In contrast, native I Cl.vol in rabbit portal vein smooth muscle cells exhibits the opposite regulation by PKC, in that currents are stimulated by activation of endogenous PKC (10, 42) . Diversity in the properties of native VSOACs across different tissues and cell types is well established (27, 34) , and future experiments are required to determine whether differences in PKC regulation reflect different volume-sensitive intracellular signaling pathways or different molecular entities responsible for VSOACs in different cell types. The existence of subtypes of VSOACs may explain the apparent unaltered properties of native VSOACs in two cell types examined (pancreatic cells and hepatocytes) from mice with disrupted ClC-3 (Clcn Ϫ/Ϫ knockout) (33). 
